Pfizer on Track to Deliver Greater Shareholder Value, CEO Kindler Tells Shareholders

Today at Pfizer´s annual shareholder meeting

Chairman and Chief Executive Officer Jeffrey B. Kindler detailed his

plan to build on the Company´s foundation to

drive greater shareholder return.
"Operationally, in 2007, we took a series of

significant actions to better position Pfizer to meet our challenges and

to seize the many opportunities before us in the growing global

marketplace for better healthcare," Mr.

Kindler said. "Of course, we are far from done "“ and our progress is not yet reflected in the share price."
At the meeting, the company´s 14 directors

were re-elected to one-year terms. In other voting, shareholders

ratified the selection of KPMG as Pfizer´s

independent registered public accounting firm for the 2008 fiscal year.

The two shareholder resolutions did not receive a majority vote.